Papers
2
Total Citations
43
H-Index
2
About
Dr. Keita Izumi is a pioneering urologic surgeon whose research centers on advancing robot-assisted radical prostatectomy (RARP) through the adoption and evaluation of novel surgical platforms. His major contributions lie in the clinical implementation and comparative assessment of the hinotori™ Surgical Robot System, the first made-in-Japan robotic platform for prostate cancer surgery. In his landmark 2024 study, Dr. Izumi reported the initial experience and learning curve for hinotori-assisted RARP (h-RARP), demonstrating the system’s feasibility and documenting the skill development required for safe adoption. This work, with 29 citations, established foundational evidence for the platform’s use. He further solidified hinotori’s credibility through a propensity score-matched analysis comparing h-RARP against the established da Vinci Xi system, showing comparable surgical outcomes and highlighting hinotori’s potential benefits. With 14 citations, this comparative study is critical for surgeons evaluating robotic alternatives. Dr. Izumi’s research directly impacts surgical practice by providing data-driven guidance on integrating new robotic technologies, ultimately aiming to improve patient outcomes and expand access to minimally invasive prostate surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2